Pain Treatment Topics (Pain-Topics.org) - Comment

Document ID: FDA-2011-N-0802-0003
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 31 2012, at 12:00 AM Eastern Daylight Time
Date Posted: April 12 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: November 17 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: June 12 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fe5a8f
View Document:

This is comment on Notice

Role of Naloxone in OpioidOverdose Fatality Prevention; Workshop; Request for Comments

View Comment

Many news and research articles have been decrying escalating trends in overdoses and deaths from opioid analgesics and heroin. Yet, rarely is mention made of the fact that there is an effective and safe antidote for such tragedies — naloxone. Isn’t it time to stop the complaining, and conducting pilot studies, and to start using naloxone on a broad scale to finally address and ameliorate the problems? Evidence-based comments by Stewart B. Leavitt, MA, PhD, executive director of the Pain Treatment Topics and Opioids911-Safety education projects are in an attached MS Word document.

Attachments:

Pain Treatment Topics - DocketComment-FDA-2011-N-0802-0001-from-SB_Leavitt

Title:
Pain Treatment Topics - DocketComment-FDA-2011-N-0802-0001-from-SB_Leavitt

View Attachment:

Related Comments

View All

Total: 37

Rudolph Joseph Maier, MD - Comment
Public Submission Posted: 02/28/2012 ID: FDA-2011-N-0802-0002